Jeffrey Borer is a Cardiology physician affiliated with Valve. OpenAlex indexes 542 publications with 32,827 citations (h-index 79). By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
635 Madison Ave
3rd Floor
New York, NY 100221009
Telephone
212-289-7777Registry record last updated 31 May 2026.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year20243 payments$17,550openpaymentsdata.cms.gov ↗
- Alnylam Pharmaceuticals Inc.Program year20231 payment
- Kestra Medical Technology Services, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1985–2007 per NIH RePORTER. The latest:
- Valves in the Heart of the Big Apple V: Evaluation & Management of Valvular Heart
Heart Valve Society
FY2007$10,000R13HL088909 - CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCTION
Weill Medical College of Cornell Univ
FY1988N01HV038029 - CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCTION
Weill Medical College of Cornell Univ
FY1988N01HV038029
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
New England Journal of Medicine
2018 - Incremental Benefit of Drug Therapies for Chronic Heart Failure with Reduced Ejection Fraction: A Network Meta-Analysis
European Journal of Heart Failure
2018 - Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
New England Journal of Medicine
2016 - Meta-Analysis of the Relation of Body Mass Index to All-Cause and Cardiovascular Mortality and Hospitalization in Patients With Chronic Heart Failure
The American Journal of Cardiology
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Vinod Thourani, MD
Valve
Vasilis Babaliaros, MD
Valve
Lauren Elman, MD
Valve
Isaac George, MD
Valve
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”